Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients

• Conditions: Neoplasms
• Interventions: Device: Low intensity amplitude-modulated RF EMFs

• Registration Number: NCT03037840
• Lead Sponsor: Southern Medical University, China

Brief Summary

Studies have shown that tumor specific amplitude-modulated frequencies of radiofrequency electromagnetic fields that is associated with biofeedback upon exposure to in cancer patients. However, such discovery in other cancer patients are rare. And whether tumor specific frequencies can be found in Asian cancer patients remains unclear. The purpose of this study is to detect the tumor specific frequencies of Asian cancer patients in vivo.

Detailed Description

The measurements were safety guaranteed and were conducted in hospital. Before detecting, the patient will be already diagnosed with cancer. The doctor and the operator are responsible for the detecting. When cancer patients are exposure to the RF electromagnetic fields, the radial pulse amplitude, blood pressure, skin electrical resistance and breath will be monitored. Biofeedback parameters will be recorded at different modulation frequencies and analyzed in order to find the variation and tumor specific frequencies.

Study Timeline

• Study First Submitted: 2016-07-06
• Study First Submitted QC: 2016-07-06
• Study First Posted: 2017-01-31
• Status Verified: 2018-10
• Last Update Submitted: 2018-10-11
• Last Update Posted: 2018-10-12
• Study Start: 2018-12
• Primary Completion: 2019-06
• Study Completion: 2020-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Clinical diagnosis of cancer Disease

Exclusion Criteria

• other patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
healthy participators	Low intensity amplitude-modulated RF EMFs	Low intensity amplitude-modulated RF EMFs
cancer patients	Low intensity amplitude-modulated RF EMFs	Low intensity amplitude-modulated RF EMFs

Primary Outcome Measures

Name	Time	Method
Biofeedback response of cancer patients at the exposure of Low intensity amplitude-modulated radiofrequency electromagnetic fields	within 20 min of exposure

Secondary Outcome Measures

Name	Time	Method
Representation of autonomous response during the exposure of tumor specific frequencies modutated RF eletromagnetic fields	within 20 min of exposure